Exactech received FDA 510(k) clearance to market the Vantage™ Total Ankle. Targeted clinical evaluation will commence in mid-2016, with full launch slated for 1Q17.
Worldwide orthopaedic product sales reached $46.6 billion in 2015, an increase of 1.2 percent over 2014, according to ORTHOWORLD estimates. The numbers cited in the latest installment of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT show that industry growth slowed from the two to three percent range in recent years due to various economic and industry factors.
BD sold its vertebral augmentation assets, including all AVAmax®, AVAflex®, AVAtex® and AVAprep® branded products, to Stryker. Financial terms were not disclosed.
RTI Surgical entered the posterior laminoplasty market with launch of the Release® Laminoplasty Fixation system, indicated for central spinal cord decompression from C3 to T3.
FDA’s Orthopaedic and Rehabilitation Devices Panel recommended premarket approval of Cartiva’s Synthetic Cartilage Implant for the treatment of osteoarthritis in the great toe.
As declining margins squeeze every facet of orthopaedics and reimbursement undergoes yet another change, independent surgeons seek to diversify their practices to protect existing revenue and develop new streams. Some are aligning with or opening an orthopaedic urgent care center. In turn, the growth of orthopaedic urgent cares has attracted interest from other industry stakeholders, like major hospital systems and device distributors.